What works now
Clinical and functional outcomes in defined populations.
Explore →
We track the science attempting to slow ageing, repair biological damage and extend healthy human life.
Human case study · A first-in-human report described porcine kidney transplantation followed later by a human transplant.
Sponsor announcement · The sponsor reported the first patient dosed in the ER-100 eye study.
Sponsor report / conference results · GRAIL presented NHS-Galleri results at ASCO.
Automatically collected research · Not yet reviewed by Ethernia. Topic tags describe title keywords, not evidence strength. Listings may include reviews and animal or laboratory studies.
Loading research listings…
Publication dates supplied by Europe PMC. Indexing can lag publication. Newest matches from a rolling 120-day search; this is not a complete literature review.
Clinical and functional outcomes in defined populations.
Explore →Useful human signals that still need validation.
Explore →Experimental attempts to change tissue function.
Explore →The thresholds for radically longer human life.
Explore →Different technologies address different limits. Follow their path from biological rationale to a result in humans.
Open the frontier map ↗A large randomized outcome trial provides a useful benchmark for longevity claims.
Human molecular signals, exercise trade-offs and the unfinished test of geroprotection.
A 2025 randomized trial moves mitochondrial quality control into a measurable human question.